IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MUSSONI, LUCIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6315
NA - Nord America 3281
AS - Asia 1798
SA - Sud America 62
Continente sconosciuto - Info sul continente non disponibili 18
AF - Africa 8
OC - Oceania 6
Totale 11488
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3191
GB - Regno Unito 2763
CN - Cina 893
DE - Germania 844
SE - Svezia 799
IT - Italia 753
TR - Turchia 300
KR - Corea 224
UA - Ucraina 216
RU - Federazione Russa 183
FR - Francia 175
IE - Irlanda 163
EU - Europa 145
NL - Olanda 122
IN - India 117
JP - Giappone 112
FI - Finlandia 110
CA - Canada 83
PL - Polonia 70
PH - Filippine 53
VN - Vietnam 51
CO - Colombia 47
GR - Grecia 46
BE - Belgio 38
ID - Indonesia 24
BR - Brasile 9
DK - Danimarca 9
CH - Svizzera 5
AU - Australia 4
IR - Iran 4
JM - Giamaica 4
SG - Singapore 4
TW - Taiwan 4
CL - Cile 3
HK - Hong Kong 3
HU - Ungheria 3
MX - Messico 3
RO - Romania 3
AR - Argentina 2
ES - Italia 2
ML - Mali 2
NG - Nigeria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
UZ - Uzbekistan 2
AM - Armenia 1
AT - Austria 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EC - Ecuador 1
HR - Croazia 1
IL - Israele 1
LV - Lettonia 1
LY - Libia 1
MY - Malesia 1
PT - Portogallo 1
SA - Arabia Saudita 1
SI - Slovenia 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 11615
Salva come PNG Salva come JPEG
Città #
Southend 2640
Chandler 404
Seattle 306
Wilmington 274
Milan 254
Princeton 253
Beijing 197
Hanover 195
Dublin 163
Redmond 155
Boise 138
Ann Arbor 134
Mountain View 130
Nanjing 125
Jacksonville 124
Dearborn 108
Sakarya 106
Fairfield 102
Munich 88
Des Moines 77
Serra 76
Somerville 64
Woodbridge 64
Ashburn 62
Boardman 59
Jinan 59
Andover 56
Toronto 53
Shenyang 51
Warsaw 50
Grafing 48
Bogotá 47
Athens 45
Cambridge 45
Centro 45
Hebei 42
Houston 40
Bitonto 39
Brussels 37
Nanchang 37
Berlin 35
Changsha 35
Kansas City 35
Seoul 32
Zhengzhou 30
Hangzhou 29
Guangzhou 25
Nürnberg 25
Tanggu 25
Kiez 24
Medford 23
Tianjin 23
Ottawa 22
Redwood City 21
Phoenix 18
Scranton 18
Taizhou 18
Dong Ket 17
Jiaxing 17
Ningbo 17
Roxbury 17
Rome 15
San Diego 15
Hamburg 14
Haikou 12
Kunming 12
Lanzhou 11
Payette 11
Pisa 11
San Jose 11
Taiyuan 11
Washington 11
Osaka 10
Turin 10
Auburn Hills 9
Norwalk 9
Padova 9
Costa Mesa 8
Falls Church 8
Margão 8
Saint Petersburg 8
São Paulo 7
Hefei 6
Istanbul 6
Lewiston 6
London 6
Mumbai 6
Ponderay 6
Shanghai 6
Trieste 6
Florence 5
New York 5
Orofino 5
Shangdi 5
Tokyo 5
Torino 5
Atlanta 4
Bangalore 4
Fuzhou 4
Garden Valley 4
Totale 7812
Salva come PNG Salva come JPEG
Nome #
Effect of valsartan on angiotensin II-induced plasminogen activator inhibitor-1 biosynthesis in arterial smooth muscle cells 368
Plasma fibrinogen concentration predicts the risk of myocardial infarction differently in various parts of Europe: effects of beta-fibrinogen genotype and environmental factors. The HIFMECH Study 301
Pentoxifylline prevents spontaneous brain ischemia in stroke-prone rats 216
Minor components of olive oil affect the expression of pro-atherogenic molecules and cGMP-dependent PDE5 activity 201
D-dimer is associated with arterial and venous coronary artery bypass graft occlusion 187
Effect of n-3 fatty acids on carotid atherosclerosis and hemostasis in hypertriglyceridemic patients: a double blind pilot study in primary prevention 181
Lipoproteine aterogene e sintesi di PAI-1 da parte di cellule endoteliali 179
Neurohormonal activation is associated with increased levels of plasma matrix metalloproteinase-2 in human heart failure 169
Lipoproteine aterogene e trombosi: aspetti cellulari 159
Increased prothrombotic state lasting as long as one month after on-pump and off-pump coronary surgery 157
Antithrombotic and anti-inflammatory properties of rosuvastatin in cultured human endothelial cells 156
Plasminogen activator inhibitor type-1 synthesis and mRNA expression in HepG2 cells are regulated by VLDL 151
Association of increased fibrin turnover and defective fibrinolytic capacity with leg atherosclerosis. The PLAT Group 150
LDL-acetilate e sintesi di PAI-1 da parte di cellule endoteliali: ruolo del recettore scavenger 145
Effect of n-3 fatty acids on carotid atherosclerosis and haemostasis in patients with combined hyperlipoproteinemia: a double-blind pilot study in primary prevention 141
Rosuvastatin exerts renoprotective effects in stroke-prone rats independently of changes in cholesterol levels 140
The ATROCAP Study: atorvastatin and the thrombogenicity of carotid atherosclerotic plaque 138
Minor components of olive oil modulate proatherogenic adhesion molecules involved in endothelial activation 135
La rosuvastatina previene il danno renale spontaneo nei ratti SHRSP modulando il sistema plasminogeno/plasmina e l’espressione delle metalloproteasi 135
Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study 135
Vascular thrombogenicity induced by progressive LDL oxidation : protection by antioxidants 133
Proteomic analysis of membrane microdomains derived from both failing and non-failing human hearts 130
Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group 130
Effect of omega-3 PUFA on carotid IMT and haemostasis in hypertriglyceridemic patients: a longitudinal pilot study in primary prevention 130
Gender differences in endothelial function and inflammatory markers along the occurrence of pathological events in stroke-prone rats 128
Proteome of endothelial cell-derived procoagulant microparticles 126
Rosuvastatin exerts renoprotective effects in stroke-prone rats by modulating the plasminogen/plasmin system and the metalloproteases expression 125
Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats 124
Statins prevent tissue factor induction by protease-activated receptors 1 and 2 in human umbilical vein endothelial cells in vitro 124
Triglycerides and the fibrinolytic system 121
Cytokines present in smokers' serum interact with smoke components to enhance endothelial dysfunction 120
Tissue factor induction by protease-activated receptor 1 requires intact caveolin-enriched membrane microdomains in human endothelial cells 118
Triglycerides and the fibrinolytic system 118
Additive effect of triglyceride and insulin as determinants of plasminogen activator inhibitor-1 levels in normo and hypertriglyceridemic subjects 118
Rosuvastatin exerts renoprotective effects in stroke-prone rats by modulating the plasminogen/plasmin system and metalloproteases expression 117
Bezafibrate lowers plasma lipids, fibrinogen and platelet aggregability in hypertriglyceridaemia 116
Distinct roles for PAR1- and PAR2-mediated vasomotor modulation in human arterial and venous conduits 115
Effects of native and modified low density lipoproteins on functional and biochemical aspects of cells involved in the thrombotic process 115
Generation and characterization of a stable rat adult brain endothelial cell line 114
PAR-1 and PAR-2 activation mediates tissue factor induction in endothelial cells through a redox-sensitive signaling pathway 114
Mitochondrial reactive oxygen species : a common pathway for PAR1- and PAR2-mediated tissue factor induction in human endothelial cells 114
Atherosclerotic plaque as a therapeutic target. The ATROCAP Study (Atorvastatin and Thrombogenicity of Carotid Atherosclerotic Plaque). 113
Systemic inflammation after on-pump and off-pump coronary bypass surgery: a one-month follow-up 112
The role of tissue factor and P-selectin in the procoagulant response that occurs in the first month after on-pump and off-pump coronary artery bypass grafting 110
Hyperlipidemias and the fibrinolytic system 109
Prostacyclin reduction results in tissue factor (TF) upregulation and predisposes cyclooxygenase-2 knockout (COX-2KO) mice to thrombosis 108
Proteome of platelets in patients with coronary artery disease 107
Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs. An LDL receptor-independent phenomenon 107
Atherogenic lipoproteins and PAI-1 synthesis by endothelial-cells 107
Plasminogen activator inhibitor type-1 mRNA expression is increased by triglyceride rich lipoproteins in human hepatoma cells 106
Expression of alternatively spliced tissue factor in human endothelial cells : induction by inflammatory stimuli and modulation by heparins 105
Hypertriglyceridemia and regulation of fibrinolytic activity 105
Parnaparin reduces the extent of damage in rat brain ischemia : a nuclear magnetic resonance imaging study 104
Proteomic analysis of plasma from patients undergoing coronary artery bypass grafting reveals a protease/antiprotease imbalance in favor of the serpin alpha1-antichymotrypsin 104
REGULATION OF PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 BY ACETYL-LDL IN HUMAN UMBIUCAL VEIN ENDOTIIELIAL CELLS 104
Effetto delle VLDL sull'espressione di mRNA per il PAI-1 in cellule HepG2 104
Effect of triglycerides and triglyceride rich lipoproteins on fibrinolytic system 104
Triglycerides and the fibrinolytic system: in vitro regulation of the synthesis of plasminogen activator type 1 by triglyceride-rich lipoproteins in HepG2 cells 104
Distinct roles for PAR-1 and PAR-2 mediated vasomotor modulation in human arterial and venous conduits used in coronary artery bypass surgery 103
Lipoproteine aterogene ed endotelio vascolare 102
Nonrheumatic calcific aortic stenosis : an overview from basic science to pharmacological prevention 100
Rosuvastatin exerts renoprotective effects in stroke-prone rats modulating the plasminogen/plasmin and metalloprotease systems 99
Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells 99
Very low density lipoprotein-mediated signal transduction and plasminogen activator inhibitor type 1 in cultured HepG2 cells 98
Effect of atherogenic lipoproteins on PAI-1 synthesis by endothelial cells 98
Effects of triglyceride rich lipoproteins on the synthesis of plasminogen activator inhibitor 1 (PAI-1) by HepG2 cells 98
An increased prothrombotic state lasts up to one month after on-pump and off-pump coronary surgery 98
Antithrombotic and antiinflammatory properties of rosuvastatin in culured human endothelial cells. 97
Antithrombotic and antiinflammatory properties of rosuvastatin in cultured human endothelial cells. 97
Additive effect of triglyceride and insulin as determinants of plasminogen activator inhibitor-1 levels in normo and hypertriglyceridemic subjects 97
Distinct roles for PAR1 and 2-mediated vasomotor modulation in human arterial and venous conduits used in coronary artery by pass surgery 97
Transcriptional regulation of plasminogen activator inhibitor type 1 gene by insulin: insights into the signaling pathway 96
Proteomic analysis of plasma from patients undergoing coronary artery bypass grafting reveals a protease/anti-protease imbalance in favor of the serpin alpha1-antichymotrypsin 95
Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery 95
Protein-Kinase-C inhibitors and gemfibrozil prevent the enhancing effect of very low density lipoproteins on the biosynthesis of plasminogen activator inhibitor type 1 by HepG2 cells 95
Effect of atorvastatin on coagulation and inflammatory variables in patients with bilateral carotid stenosis. 95
Proteome of endothelial cell-derived procoagulant microparticles 93
Protease-activated receptors 1 and 2 activation induces tissue factor through mitochondrial reactive oxygen species 92
Induzione del PAI-1 da parte di VLDL in cellule HEPG2: meccanismi di trasduzione 92
PAR-1 and PAR-2 activation mediates tissue factor induction in endothelial cells through a redox-sensitive signaling pathway 91
Effect of omega-3 PUFA on carotid IMT and hemostasis in hypertriglyceridemic patients: a longitudinal pilot study in primary prevention 91
Oxidized LDLs influence thrombotic response and cyclooxygenase 2 90
Proteomic analysis of membrane microdomains derived from both failing and non-failing human hearts 87
Tissue factor induction by protease-activated receptor-1 requires intact caveolin-enriched membrane microdomains in human endothelial cells 87
Influence of atherogenic lipoproteins on the thrombotic potential of endothelial cells 86
Effects of protein kinase C inhibitors and of gemfibrozil on the biosynthesis of plasminogen activator inhibitor type 1 by HepG2 cells exposed to very low density lipoproteins 84
Tissue factor expression and apoptosis induced by oxidised low density lipoptoteins on human umbilical endothelials cells are prevented by antioxidants 83
Triglycerides as predictor of tissue activator and of tissue plasminogen activator inhibitor type 1 levels in non obese normo and hypertriglyceridemic subjects 83
Endothelial tissue factor induction by T lymphocytes in systemic sclerosis 82
Endogenous proteolytic activity in a rat model of spontaneous cerebral stroke 81
Neurohormonal activation is associated with increased levels of plasma MMP-2 in human heart failure 80
The effect of synthetic malaria pigment (beta-haematin) on adhesion molecule expression and interleukin-6 production by human endothelial cells 78
Increased thrombogenic potential of human monocyte-derived macrophages spontaneously transformed into foam cells 76
Isoprostanes and oxidative stress in off-pump and on-pump coronary bypass surgery 74
PAR-1 and PAR-2 activation mediates tissue factor induction in endothelial cells through a redox-sensitive signaling pathway 74
Signaling pathways involved in the induction of PAI-1 by VLDL in HEPG2 cells 73
n-3 PUFA which mechanisms? 72
Farmaci fibrinolitici 70
Relationship between fibrinolytic and metabolic variables: a study in patients attending a lipid clinic 69
One month follow-up of haemostatic variables in patients undergoing aortocoronary bypass surgery. Effect of aprotinin 68
Totale 11622
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18595
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18595
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018300 0000 00 00 0020199
2018/20191473 36811011379 11190 19061 1061046675
2019/20201432 218166455 67160 20956 20024410043
2020/20211415 3216012718 13496 6342 1885740890
2021/20221523 1326996107 96165 11280 106122208230
2022/20231564 285164127194 148302 4783 13135480
Totale 12384